Business Standard

Covid-19: ICMR invites application for validation of rapid antigen tests

So far, ICMR has validated and approved only one rapid antigen detection assay from SD Biosensor, a South Korea based company, having its manufacturing unit in Manesar,Gurgaon

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

All hospitals, labs, state governments intending to perform the point-of-care antigen test need to register with ICMR to obtain the login credentials for data entry

Press Trust of India New Delhi
The ICMR on Thursday invited applications for validation of rapid antigen detection tests for Covid-19from all manufacturers who have developed such kits as part of its efforts to scale up testing capacity with faster diagnosis.
The rapid antigen test allows faster diagnosis without laboratory examination of samples and results are available within 30minutes.
The ICMR has identified six sites -- AIIMS, Delhi; SMS Medical College in Jaipur; King George Medical University, Lucknow; Kasturba Hospital for Infectious Diseases, Mumbai;PGIMER inChandigarh; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry and NIV, Kerala unit, Alappuzha -- for validation of the rapid point-of-care antigen detection
Topics : Coronavirus

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in